Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction.
about
Physiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug deliveryTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Expression and clinical significance of multidrug resistance proteins in brain tumors.Cellular accumulation and activity of quinolones in ciprofloxacin-resistant J774 macrophagesExpression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells.Impact of ABCB1 allelic variants on QTc interval prolongation.ABCB1 C3435T polymorphism is associated with leukemia susceptibility: evidence from a meta-analysisIdentification of P-glycoprotein co-fractionating proteins and specific binding partners in rat brain microvessels.Role of gamma-synuclein in microtubule regulation.Proteasomal inhibition stabilizes topoisomerase IIalpha protein and reverses resistance to the topoisomerase II poison ethonafide (AMP-53, 6-ethoxyazonafide)FXR and PXR: potential therapeutic targets in cholestasis.A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin.P-glycoprotein transporter in drug development.P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia.Verotoxin-1 treatment or manipulation of its receptor globotriaosylceramide (gb3) for reversal of multidrug resistance to cancer chemotherapy.P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery.The stabilisation of purified, reconstituted P-glycoprotein by freeze drying with disaccharides.Thyroxine (T4) Transfer from Blood to Cerebrospinal Fluid in Sheep Isolated Perfused Choroid Plexus: Role of Multidrug Resistance-Associated Proteins and Organic Anion Transporting Polypeptides.Vincristine-cyclophosphamide combination therapy positively affects T-cell subset distribution in systemic lupus erythematosus patients.
P2860
Q26861408-3E6EE06E-E6B2-4BC7-8EE2-9F3CFB5DAD1AQ27690256-73143806-5190-477E-9A4E-E6AD89EC7973Q33684017-F11548DA-E947-4DA9-B5E4-AAF52AA6B907Q34648829-EBF278A2-F6AD-402D-8CBF-ECD506A5262BQ34774983-5038057F-41FA-4E35-B777-43D374925D63Q34781769-B3A04D5F-89A2-4FC4-B999-303DF9E475BEQ35593505-29E52B47-5DC7-4E53-B019-92D3B69B06FCQ35815787-85D65B25-3EDE-4EFD-BBBF-5D07E8B7E5AEQ35885349-0218513E-3AD0-43D4-8073-FA5758E5802FQ36502978-39816B36-87C1-4224-B797-F31273AD5174Q36572561-4F0EF8DC-258E-404F-8192-277CBF24B9B3Q36696272-C4EEFF67-335E-4FB1-911B-45A71E0AB819Q36755799-9E5C78B4-F30B-4D4B-BF39-4471161E949EQ37364487-55F0EE32-9081-4C7D-831F-9142A16274C5Q37954271-74045B0F-5AC5-4837-8BC8-A2820D12CA42Q38259301-BDDBAB69-DA93-440B-A045-E8720183CBD2Q41828061-3851A884-BE1D-47B3-B1A4-D3B3F088CBAAQ42251253-6D340610-CE4A-460F-A85F-7A57A7DD7459Q43156580-553228FB-5B39-4323-9734-4962648FB857
P2860
Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Multidrug resistance P-glycopr ...... g disposition and interaction.
@ast
Multidrug resistance P-glycopr ...... g disposition and interaction.
@en
type
label
Multidrug resistance P-glycopr ...... g disposition and interaction.
@ast
Multidrug resistance P-glycopr ...... g disposition and interaction.
@en
prefLabel
Multidrug resistance P-glycopr ...... g disposition and interaction.
@ast
Multidrug resistance P-glycopr ...... g disposition and interaction.
@en
P2093
P1476
Multidrug resistance P-glycopr ...... ug disposition and interaction
@en
P2093
Gang Cheng
Mei-Juan Zou
Shu-Jun Wang
Xiu-Hua Hao
Zhong-Gui He
P304
P577
2004-01-01T00:00:00Z